Burinex 1 mg Tablets
PDF Leaflet Revision Date: 20 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of oedema associated with heart failure, renal disease, and hepatic ascites.
Dosage (summary)
1 mg daily, may increase based on response; consider twice daily for refractory cases.
Onset of Action / Duration
Onset: 30 mins, Duration: 4-6 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Diabetic patients
Pregnancy & Breastfeeding
Avoid in first trimester; contraindicated in breastfeeding.
Key Drug Interactions
- Digitalis glycosides
- Antihypertensives
- NSAIDs
- Lithium
- Potassium depleting medicines
Contraindications
- Hypersensitivity to bumetanide
- Anuria
- Hepatic coma
- Electrolyte depletion
Common side effects
- Headache
- Dizziness
- Electrolyte disturbances
- Fatigue
- Abdominal pain
Counselling Points
- Monitor for dizziness
- Maintain potassium intake
- Report signs of SJS or TEN
Serious warnings
- Risk of SJS and TEN
- Electrolyte imbalance
- Caution in hypotension
Important Disclaimer
The Burinex 1 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
